CD4 and AIDS: The aim of the present study was to assess whether immune-recovery during virological successful HAART among late-presenters (i.e., patients with pre-HAART CD4+ count <200 cells/μl) is associated with the risk of severe non-AIDS related morbidity and mortality, independently of possible confounders.